Recent Advances in Varicella-Zoster Virus Infection

  1. Moderator: Jeffrey I. Cohen, MD;
  2. Discussants: Philip A. Brunell, MD;
  3. Stephen E. Straus, MD; and
  4. Philip R. Krause, MD
    1. Figure 1. The genome is arranged in unique long ( ), unique short ( ), terminal repeat long ( ), terminal repeat short ( ), and internal repeat ( ) regions. Selected immediate-early ( ), early ( ), late ( ), and latency-associated genes are shown. ssDNA = single-stranded DNA.
      View larger version:
      Figure 1. The genome is arranged in unique long ( ), unique short ( ), terminal repeat long ( ), terminal repeat short ( ), and internal repeat ( ) regions. Selected immediate-early ( ), early ( ), late ( ), and latency-associated genes are shown. ssDNA = single-stranded DNA. Structure of the varicella-zoster virus genome and position of selected genes.U L U S TR L TR S IRIEEL
    2. Figure 2. A child with varicella who had onset of rash 2 weeks after his sibling ( ) had zoster. The rash is in different stages of evolution, with some vesicles, macules, and papules. The rash is generalized and, in this early stage, mainly on the trunk. The thigh of a child recovering from varicella complicated by necrotizing fasciitis due to group A streptococci. A child with zoster. The rash is unilateral in the distribution of the third and fourth thoracic dermatomes. Verrucous lesions on the foot of an HIV-positive child with progressive varicella who had been treated for several months with antiviral drugs without resolution of the lesions (reproduced with permission from Srugo and colleagues ). A vesicular lesion on the thumb ( ) and papular lesions on the face ( ) of a child who had previously received varicella vaccine. A generalized maculopapular rash in a child who had received varicella vaccine 9 days previously.
      View larger version:
      Figure 2. A child with varicella who had onset of rash 2 weeks after his sibling ( ) had zoster. The rash is in different stages of evolution, with some vesicles, macules, and papules. The rash is generalized and, in this early stage, mainly on the trunk. The thigh of a child recovering from varicella complicated by necrotizing fasciitis due to group A streptococci. A child with zoster. The rash is unilateral in the distribution of the third and fourth thoracic dermatomes. Verrucous lesions on the foot of an HIV-positive child with progressive varicella who had been treated for several months with antiviral drugs without resolution of the lesions (reproduced with permission from Srugo and colleagues ). A vesicular lesion on the thumb ( ) and papular lesions on the face ( ) of a child who had previously received varicella vaccine. A generalized maculopapular rash in a child who had received varicella vaccine 9 days previously. Dermatologic manifestations of varicella and zoster. A.CB.C.D.[27]E.EaEbF.
    3. Figure 3. / Although intracellular drug triphosphate concentrations are more relevant, this schematic provides some explanation for the advantages of intravenous acyclovir ( ), oral valacyclovir ( ), and oral famciclovir ( ) relative to standard high-dose (800 mg) oral acyclovir ( ). id = per day; IV = intravenous; PO = oral; Q8h = every 8 hours.
      View larger version:
      Figure 3. / Although intracellular drug triphosphate concentrations are more relevant, this schematic provides some explanation for the advantages of intravenous acyclovir ( ), oral valacyclovir ( ), and oral famciclovir ( ) relative to standard high-dose (800 mg) oral acyclovir ( ). id = per day; IV = intravenous; PO = oral; Q8h = every 8 hours. Approximate peak serum blood levels of antiviral drugs and the 50% effective dose (ED50) in vitro concentrations required to inhibit replication of the herpes simplex virus (HSV) or the varicella-zoster virus (VZV).ACVVCVFCVACV
    « Previous | Next Article »Table of Contents

    This Article

    1. Ann Intern Med June 1, 1999 vol. 130 no. 11 922-932
    1. AbstractFREE
    2. » Figures
    3. Full Text
    4. Full Text (PDF)

    Rapid Responses

    1. Submit a response
    2. No responses published

    Current Issue

    1. November 17, 2009, 151 (10)
    1. Alert me to current issues